About Aeterna Zentaris
Aeterna Zentaris develops Macrilen (macimorelin) for adult growth hormone deficiency diagnosis and conducts research on LHRH antagonists for prostate cancer and reproductive medicine.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Aeterna Zentaris. Response typically within 48 hours.
Company Info
TypePublic
StockAEZS (NASDAQ)
Founded1990
Employees30
Revenue$5M
HQSummerville, Canada
